7 Recruiting Multiple Myeloma Clinical Trials in Texas
Explore active multiple myeloma research studies enrolling across Texas. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Multiple Myeloma Studies in Texas
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
📍 Harris Health Ben Taub Hospital — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
ATRA and Carfilzomib in Plasma Cell Myeloma Patients
📍 Houston Methodist Neal Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab
📍 The University of Texas MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔